You are viewing the site in preview mode
Skip to main content
Influences for substitution (%)
Substance type
Use n (%)
Substitution (%)
Experiences
Healthcare provider
Dispensary
Individuals
Other
Amphetamines
52 (19%)
75
89
11
0
3
14
Anticonvulsants
30 (13%)
70
87
22
4
8
4
Antidepressants
141 (51%)
53
93
22
7
6
6
Antiemetics
33, 12%
79
87
13
4
0
4
Antihistamines
94, 34%
36
100
3
0
3
6
Antipsychotics
19 (7%)
78
71
43
0
7
0
Anxiolytics or benzodiazepines
64 (23%)
73
87
34
4
8
8
Muscle relaxers
107 (39%)
82
88
15
3
5
11
Non-opioid pain relievers
93 (34%)
76
97
10
4
6
12
Nonsteroidal anti-inflammatories
125 (46%)
62
92
14
3
4
9
Opioids
102 (37%)
86
88
28
11
9
12
Non-amphetamine stimulants
19 (7%)
50
89
11
0
11
22
Prescription cannabinoids
5 (2%)
75
75
0
0
25
25
Sedatives
34 (12%)
88
93
25
7
4
14
Sleep aids
79 (29%)
83
95
15
6
8
5
Steroids
44 (16%)
64
55
18
2
0
2
N = 275 participants total, 192 of whom reported any substitution. Note: all values are proportions of relevant groups. Use indicates proportion of participants who have used a substance. Substitution indicates proportion of participants using a substance who have reduced or stopped their use because of medical cannabis. Influences for substitution include participant’s own experimentation and experiences, advice from primary health/medical care provider, advice from my medical marijuana caregiver/dispensary, advice from other individual(s), and other source of informationPCP primary care provider
